China SXT Pharmaceuticals (NASDAQ:SXTC) Given "Sell (E+)" Rating at Weiss Ratings

Key Points

• Weiss Ratings has reissued a "Sell (E+)" rating for China SXT Pharmaceuticals (NASDAQ:SXTC), indicating strong concerns over the company's stock performance.
• In contrast, Wall Street Zen has upgraded the company from a "sell" rating to a "hold" rating, suggesting a mixed outlook from different analysts.
• As of trading on Wednesday, shares of China SXT Pharmaceuticals were down to $1.56, a significant decline from its one-year high of $7.84.

China SXT Pharmaceuticals (NASDAQ:SXTC - Get Free Report)'s stock had its "sell (e+)" rating reissued by investment analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen upgraded China SXT Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Saturday, August 2nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of "Sell".

China SXT Pharmaceuticals Price Performance

Shares of NASDAQ:SXTC traded down $0.08 during trading on Wednesday, reaching $1.56. 32,272 shares of the stock were exchanged, compared to its average volume of 109,840. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.54 and a quick ratio of 3.40. China SXT Pharmaceuticals has a 1-year low of $0.95 and a 1-year high of $7.84. The stock has a fifty day moving average of $1.62 and a two-hundred day moving average of $1.82.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc, a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.